179 related articles for article (PubMed ID: 31310125)
1. 2-Amino-2,3-dihydro-1
Zhu D; Huang H; Pinkas DM; Luo J; Ganguly D; Fox AE; Arner E; Xiang Q; Tu ZC; Bullock AN; Brekken RA; Ding K; Lu X
J Med Chem; 2019 Aug; 62(16):7431-7444. PubMed ID: 31310125
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 4-amino-1H-pyrazolo[3,4-d]pyrimidin derivatives as novel discoidin domain receptor 1 (DDR1) inhibitors.
Dong R; Zhou X; Wang M; Li W; Zhang JY; Zheng X; Tang KX; Sun LP
Bioorg Med Chem; 2021 Jan; 29():115876. PubMed ID: 33246255
[TBL] [Abstract][Full Text] [Related]
3. Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma.
Tao Y; Wang R; Lai Q; Wu M; Wang Y; Jiang X; Zeng L; Zhou S; Li Z; Yang T; Yao Y; Wu Y; Yu L; Fu Y; Lai W; Peng Y; Lu Y; Zhang Z; Guo C; Zhang G; Gou L; Yang J
Mol Oncol; 2019 Sep; 13(9):1855-1873. PubMed ID: 31116512
[TBL] [Abstract][Full Text] [Related]
4. Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines.
Azizi R; Fallahian F; Aghaei M; Salemi Z
Anticancer Agents Med Chem; 2020; 20(8):1009-1016. PubMed ID: 32275493
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.
Wang Z; Bian H; Bartual SG; Du W; Luo J; Zhao H; Zhang S; Mo C; Zhou Y; Xu Y; Tu Z; Ren X; Lu X; Brekken RA; Yao L; Bullock AN; Su J; Ding K
J Med Chem; 2016 Jun; 59(12):5911-6. PubMed ID: 27219676
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.
Liu L; Hussain M; Luo J; Duan A; Chen C; Tu Z; Zhang J
Chem Biol Drug Des; 2017 Mar; 89(3):420-427. PubMed ID: 27589335
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2- a]pyrazin-3-ylethynyl)-4-isopropyl- N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2.
Wang Z; Zhang Y; Pinkas DM; Fox AE; Luo J; Huang H; Cui S; Xiang Q; Xu T; Xun Q; Zhu D; Tu Z; Ren X; Brekken RA; Bullock AN; Liang G; Ding K; Lu X
J Med Chem; 2018 Sep; 61(17):7977-7990. PubMed ID: 30075624
[TBL] [Abstract][Full Text] [Related]
8. Discovery of
Liu L; Zhao L; Yang L; Chai M; Liu Z; Ma N; Wang Y; Wu Q; Guo J; Zhou F; Huang W; Ren X; Wang J; Ding M; Wang Z; Ding K
J Med Chem; 2024 May; 67(10):8043-8059. PubMed ID: 38730324
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma.
Aguilera KY; Huang H; Du W; Hagopian MM; Wang Z; Hinz S; Hwang TH; Wang H; Fleming JB; Castrillon DH; Ren X; Ding K; Brekken RA
Mol Cancer Ther; 2017 Nov; 16(11):2473-2485. PubMed ID: 28864681
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines.
Azizi R; Salemi Z; Fallahian F; Aghaei M
J Cell Physiol; 2019 Nov; 234(11):19539-19552. PubMed ID: 30963567
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of EP300 and DDR1 synergistically alleviates pulmonary fibrosis in vitro and in vivo.
Tao J; Zhang M; Wen Z; Wang B; Zhang L; Ou Y; Tang X; Yu X; Jiang Q
Biomed Pharmacother; 2018 Oct; 106():1727-1733. PubMed ID: 30119248
[TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of DDR1 Inhibitors with a Desired Pharmacophore Using Deep Generative Models.
Yoshimori A; Asawa Y; Kawasaki E; Tasaka T; Matsuda S; Sekikawa T; Tanabe S; Neya M; Natsugari H; Kanai C
ChemMedChem; 2021 Mar; 16(6):955-958. PubMed ID: 33289306
[TBL] [Abstract][Full Text] [Related]
13. A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present).
Guo J; Zhang Z; Ding K
Expert Opin Ther Pat; 2020 May; 30(5):341-350. PubMed ID: 32077340
[No Abstract] [Full Text] [Related]
14. Discoidin domain receptors: A promising target in melanoma.
Reger de Moura C; Battistella M; Sohail A; Caudron A; Feugeas JP; Podgorniak MP; Pages C; Mazouz Dorval S; Marco O; Menashi S; Fridman R; Lebbé C; Mourah S; Jouenne F
Pigment Cell Melanoma Res; 2019 Sep; 32(5):697-707. PubMed ID: 31271515
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Pyrazolo[3,4-
Tan X; Li C; Yang R; Zhao S; Li F; Li X; Chen L; Wan X; Liu X; Yang T; Tong X; Xu T; Cui R; Jiang H; Zhang S; Liu H; Zheng M
J Med Chem; 2022 Jan; 65(1):103-119. PubMed ID: 34821145
[TBL] [Abstract][Full Text] [Related]
16. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.
Song J; Chen X; Bai J; Liu Q; Li H; Xie J; Jing H; Zheng J
Tumour Biol; 2016 Aug; 37(8):11509-21. PubMed ID: 27020590
[TBL] [Abstract][Full Text] [Related]
17. Signaling by discoidin domain receptor 1 in cancer metastasis.
Gadiya M; Chakraborty G
Cell Adh Migr; 2018; 12(4):315-323. PubMed ID: 30187813
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.
Wang Z; Zhang Y; Bartual SG; Luo J; Xu T; Du W; Xun Q; Tu Z; Brekken RA; Ren X; Bullock AN; Liang G; Lu X; Ding K
ACS Med Chem Lett; 2017 Mar; 8(3):327-332. PubMed ID: 28337325
[TBL] [Abstract][Full Text] [Related]
19. DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome.
Richter H; Satz AL; Bedoucha M; Buettelmann B; Petersen AC; Harmeier A; Hermosilla R; Hochstrasser R; Burger D; Gsell B; Gasser R; Huber S; Hug MN; Kocer B; Kuhn B; Ritter M; Rudolph MG; Weibel F; Molina-David J; Kim JJ; Santos JV; Stihle M; Georges GJ; Bonfil RD; Fridman R; Uhles S; Moll S; Faul C; Fornoni A; Prunotto M
ACS Chem Biol; 2019 Jan; 14(1):37-49. PubMed ID: 30452219
[TBL] [Abstract][Full Text] [Related]
20. Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.
Hur H; Ham IH; Lee D; Jin H; Aguilera KY; Oh HJ; Han SU; Kwon JE; Kim YB; Ding K; Brekken RA
BMC Cancer; 2017 Jan; 17(1):87. PubMed ID: 28143619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
